Company registration number 15630666 (England and Wales)
FOCUS SHOCKWAVE CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
FOCUS SHOCKWAVE CLINIC LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
FOCUS SHOCKWAVE CLINIC LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
Notes
£
£
Fixed assets
Tangible assets
3
33,175
Current assets
Debtors
4
569
Cash at bank and in hand
3,304
3,873
Creditors: amounts falling due within one year
5
(49,011)
Net current liabilities
(45,138)
Net liabilities
(11,963)
Capital and reserves
Called up share capital
6
100
Profit and loss reserves
(12,063)
Total equity
(11,963)

For the financial period ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 December 2025 and are signed on its behalf by:
Mrs K A Burston
Director
Company registration number 15630666 (England and Wales)
FOCUS SHOCKWAVE CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Focus Shockwave Clinic Limited is a private company limited by shares incorporated in England and Wales. The registered office is Champion Allwoods Limited, 2nd Floor Refuge House, 33-37 Watergate Row, Chester, CH1 2LE.

1.1
Reporting period

The company was incorporated on 9 April 2024 and prepared accounts for the period to 31 March 2025. As this is the first period in which the company has prepared financial statements there is no comparative period

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate available resources to continue in operational existence for the foreseeable future. Thus the directors have adopted the going concern basis of accounting in preparing the financial statements.

1.4
Turnover

Turnover represents medical fee income at invoice value. Turnover is recognised at the time the service is provided

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Medical equipment
20% per annum on a straight line basis
Office equipment
20% per annum on a straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

FOCUS SHOCKWAVE CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Number
Total
2
FOCUS SHOCKWAVE CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 4 -
3
Tangible fixed assets
Medical equipment
Office equipment
Total
£
£
£
Cost
At 9 April 2024
-
0
-
0
-
0
Additions
40,120
490
40,610
At 31 March 2025
40,120
490
40,610
Depreciation and impairment
At 9 April 2024
-
0
-
0
-
0
Depreciation charged in the period
7,345
90
7,435
At 31 March 2025
7,345
90
7,435
Carrying amount
At 31 March 2025
32,775
400
33,175
4
Debtors
2025
Amounts falling due within one year:
£
Prepayments and accrued income
569
5
Creditors: amounts falling due within one year
2025
£
Trade creditors
450
Other creditors
47,361
Accruals and deferred income
1,200
49,011
6
Called up share capital
2025
2025
Ordinary share capital
Number
£
Issued and fully paid
Ordinary Shares A of 10p each
700
70
Ordinary Shares B of 10p each
100
10
Ordinary Shares C of 10p each
100
10
Ordinary Shares D of 10p each
100
10
1,000
100

The above shares were allotted on incorporation of the company on 9 April 2024. The B, C and D class shares have no voting rights.

FOCUS SHOCKWAVE CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 5 -
7
Related party transactions

At 31 March 2025 an amount of £703 was due from the company to Mr B J Burston and Mrs K A Burston, in respect of the credit balance on their directors' current account with the company, included in other creditors above.

 

Mr B J Burston and Mrs K A Burston, directors and shareholders of the company, are also directors and shareholders of Shropshire Hip and Knee Limited. During the period the company was advanced monies by Shropshire Hip and Knee Limited. The amount owing to Shropshire Hip and Knee Limited from the company at 31st March 2025 was £46,658, included in other creditors.

 

2025-03-312024-04-09falsefalsefalse15 December 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr B J BurstonMrs K A Burston156306662024-04-092025-03-31156306662025-03-3115630666core:PlantMachinery2025-03-3115630666core:ComputerEquipment2025-03-3115630666core:ShareCapital2025-03-3115630666core:RetainedEarningsAccumulatedLosses2025-03-3115630666core:ShareCapitalOrdinaryShareClass12025-03-3115630666core:ShareCapitalOrdinaryShareClass22025-03-3115630666core:ShareCapitalOrdinaryShareClass32025-03-3115630666core:ShareCapitalOrdinaryShareClass42025-03-3115630666core:ShareCapitalOrdinaryShares2025-03-3115630666bus:Director22024-04-092025-03-3115630666core:PlantMachinery2024-04-092025-03-3115630666core:ComputerEquipment2024-04-092025-03-3115630666core:PlantMachinery2024-04-0815630666core:ComputerEquipment2024-04-08156306662024-04-0815630666core:CurrentFinancialInstruments2025-03-3115630666bus:OrdinaryShareClass12024-04-092025-03-3115630666bus:OrdinaryShareClass22024-04-092025-03-3115630666bus:OrdinaryShareClass32024-04-092025-03-3115630666bus:OrdinaryShareClass42024-04-092025-03-3115630666bus:OrdinaryShareClass12025-03-3115630666bus:OrdinaryShareClass22025-03-3115630666bus:OrdinaryShareClass32025-03-3115630666bus:OrdinaryShareClass42025-03-3115630666bus:AllOrdinaryShares2025-03-3115630666bus:PrivateLimitedCompanyLtd2024-04-092025-03-3115630666bus:SmallCompaniesRegimeForAccounts2024-04-092025-03-3115630666bus:FRS1022024-04-092025-03-3115630666bus:AuditExemptWithAccountantsReport2024-04-092025-03-3115630666bus:Director12024-04-092025-03-3115630666bus:FullAccounts2024-04-092025-03-31xbrli:purexbrli:sharesiso4217:GBP